We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+21.5%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.75B
AUM Growth
+$332M
Cap. Flow
-$28.9M
Cap. Flow %
-0.5%
Top 10 Hldgs %
51.71%
Holding
444
New
223
Increased
65
Reduced
45
Closed
77

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$54.6M
2
KYTX icon
Kyverna Therapeutics
KYTX
+$40.8M
3
SGRY icon
Surgery Partners
SGRY
+$33.8M
4
LRMR icon
Larimar Therapeutics
LRMR
+$33.4M
5
ALHC icon
Alignment Healthcare
ALHC
+$30.6M

Top Sells

Rank Stock Value
1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$62.6M
2
SWTX
SpringWorks Therapeutics
SWTX
+$60.2M
3
BAX icon
Baxter International
BAX
+$55M
4
VKTX icon
Viking Therapeutics
VKTX
+$36.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$28.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.87%
2 Industrials 0.71%
3 Technology 0.31%
4 Consumer Discretionary 0.26%
5 Financials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRI icon
76
Darden Restaurants
DRI
$23.8B
$1.06M 0.02%
+6,335
New +$1.05M
PRGS icon
77
Progress Software
PRGS
$1.66B
$1.03M 0.02%
+19,394
New +$1.07M
NAMSW icon
78
NewAmsterdam Pharma Warrant
NAMSW
$77.8M
$1.02M 0.02%
92,787
– –
AMZN icon
79
Amazon
AMZN
$2.49T
$941K 0.02%
5,219
+2,858
+121% +$477K
EA icon
80
Electronic Arts
EA
$52.4B
$876K 0.02%
+6,602
New +$906K
APG icon
81
APi Group
APG
$16.9B
$874K 0.02%
+33,396
New +$777K
NVDA icon
82
NVIDIA
NVDA
$4.8T
$857K 0.01%
9,490
-1,970
-17% -$143K
SNX icon
83
TD Synnex
SNX
$19.5B
$813K 0.01%
+7,188
New +$747K
PII icon
84
Polaris
PII
$4.19B
$797K 0.01%
+7,960
New +$731K
OWL icon
85
Blue Owl Capital
OWL
$6.64B
$787K 0.01%
41,712
+23,496
+129% +$394K
MNKD icon
86
MannKind Corp
MNKD
$1.21B
$758K 0.01%
+167,278
New +$657K
NABL icon
87
N-able
NABL
$833M
$757K 0.01%
57,956
+44,019
+316% +$582K
WHR icon
88
Whirlpool
WHR
$2.51B
$735K 0.01%
+6,147
New +$685K
SKYT icon
89
SkyWater Technology
SKYT
$1.54B
$728K 0.01%
+71,580
New +$705K
ZTS icon
90
Zoetis
ZTS
$32.7B
$709K 0.01%
+4,189
New +$785K
DRS icon
91
Leonardo DRS
DRS
$13B
$704K 0.01%
+31,888
New +$662K
CDMO
92
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$682K 0.01%
101,789
+62,213
+157% +$428K
FCN icon
93
FTI Consulting
FCN
$5.02B
$682K 0.01%
+3,242
New +$652K
AGYS icon
94
Agilysys
AGYS
$3.21B
$674K 0.01%
+7,999
New +$647K
ACLS icon
95
Axcelis
ACLS
$3.6B
$666K 0.01%
+5,969
New +$711K
ITW icon
96
Illinois Tool Works
ITW
$85.6B
$663K 0.01%
2,470
+1,632
+195% +$424K
AMED
97
DELISTED
Amedisys
AMED
$643K 0.01%
+6,978
New +$654K
ATRC icon
98
AtriCure
ATRC
$1.95B
$631K 0.01%
+20,740
New +$695K
PAG icon
99
Penske Automotive Group
PAG
$14.4B
$625K 0.01%
+3,859
New +$589K
FTNT icon
100
Fortinet
FTNT
$111B
$616K 0.01%
+9,021
New +$601K
2 3
4
5 6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2024 Portfolio in Review

As of Q1 2024, Deerfield Management held 444 positions worth $5.75B, up 6.1% from $5.42B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q1 2024 filing shows 223 new, 65 increased, 45 reduced and 77 closed positions. Its largest new stake was BioNTech: 569,574 shares worth $52.5M. The largest sale was RayzeBio, Inc. Common Stock, an estimated $62.6M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 78% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q1 2024 buy was BioNTech: 569,574 shares worth $52.5M.
  • Deerfield Management added most to Surgery Partners in Q1 2024, an estimated $33.8M increase.
  • Deerfield Management's biggest Q1 2024 reduction was SpringWorks Therapeutics, cutting an estimated $60.2M.
  • Deerfield Management fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $62.6M.
  • Deerfield Management's ten largest holdings make up 52% of its $5.75B portfolio in Q1 2024.
  • Deerfield Management opened 223 new positions and closed 77 in Q1 2024.
  • Deerfield Management's portfolio value rose 6.1% quarter-over-quarter to $5.75B.

Based on Deerfield Management's 13F filing for Q1 2024, filed 15 May 2024.